Press releases, news stories and media library. We at Intelligent Implants are developing breakthrough bioelectronics. Here are some of the most current and up-to-date highlights.
Intelligent Implants was awarded $250,000 from the $25 million Texas Medical Center (TMC) Venture Fund, supporting early-stage health care companies. The TMC Venture Fund accomplishes one of the key tenets of the Texas Medical Center’s strategic plan by transforming innovative ideas into tangible solutions for improving health. The fund provides monetary resources to young startups in the health care space with a nexus to Houston and the Texas Medical Center. These early, but critical-stage investments heighten companies’ chances of receiving additional funding and long-term success.
As part of the collaboration with Johnson & Johnson Innovation, the angelMD Catalyst Fund will make a $50,000 investment each in Intelligent Implants. In addition, angelMD will feature Intelligent Implants on its investment platform for angelMD members to invest an additional $350,000 in the company. The investments were officially announced by Charlie Emley, Catalyst Fund Managing Partner, at the 2017 MedTech Conference in San Jose, California.
Intelligent Implants is proud to announce that they are one of the winners in J&J´s global device start-up competition. In conjunction with the Grand Opening of the Center for Device Innovation (CDI @ TMC) in the Fall 2017, Johnson & Johnson Innovation and Johnson & Johnson Medical Devices launched the CDI @ TMC QuickFire Challenge, a device-focused challenge aimed at game-changing early-stage medical device innovations across strategic
CALIN, is a new €12 million life science network to assist Irish and Welsh businesses to innovate by offering open access to a unique strategic international partnership involving 6 world leading higher educational institutions and global healthcare leaders Unilever and GE Healthcare.
With the aid of Johnson and Johnson Innovation, Intelligent Implants has opened its Houston,TX office. The Johnson & Johnson Innovation family of companies (including JLABS) helps companies efficiently access expertise, funding, services and facilities to advance business and science.
Out of 50+ submissions, only 11 most promising start-ups were chosen to showcase their innovations to the Conference attendees, potential business partners and investors.
Enterprise Ireland is the state agency responsible for supporting the development of manufacturing and internationally traded services companies. They provide funding and support for companies - from entrepreneurs with business propositions for a high potential start-up through to large companies expanding their activities. Intelligent Implants has graciously accepted funding support from EI in a collaborative effort to advance our technologies and bring research and industry to Ireland.
In version 7 of the HAX demo day, the accelerator debuted thirteen new startups from its Shenzhen-based Accelerator program, alongside ten companies from the HAX Boost program, a second stage program from SOSV Revolution offices in SF. Intelligent Implants introduced its technology to a crowd of investors, press and local and foreign entrepreneurs.